MENA Metabolic Conference
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: E-News

E-News

Ergéa Group strengthens its Senior Team with Head of Supplier Relationships and Head of International Projects

Ergéa Group strengthens its Senior Team with Head of Supplier Relationships and Head of International Projects

, 16 May 2023/in E-News /by panglobal

Ergéa Group, a prominent platform for cancer care, diagnostic imaging, and medical technology services across Europe, is pleased to announce the appointment of two key positions in its senior team. Brendan Loughran joins Ergéa Group as Head of Supplier Relationships, and Jason Long takes on the role of Head of International projects at Ergéa Group. […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/05/Brendan-Jason_news-tile.jpg 1240 1748 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-05-16 07:29:502023-05-16 07:29:50Ergéa Group strengthens its Senior Team with Head of Supplier Relationships and Head of International Projects
Nick Clare_Vendor Strategy Work Group Lead_ELRIG UK

ELRIG UK Appoints Nick Clare to Board as Vendor Strategy Work Group Lead

, 16 May 2023/in E-News /by panglobal

The European Laboratory Research & Innovation Group (ELRIG) UK today announced the appointment of Nick Clare to the ELRIG board. He will chair and lead the Vendor Strategy Work Group to help ensure the vendors’ perspectives and interests are represented within the ELRIG board.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/05/Nick-Clare_Vendor-Strategy-Work-Group-Lead_ELRIG-UK.jpg 1000 1000 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-05-16 07:17:012023-05-16 07:54:32ELRIG UK Appoints Nick Clare to Board as Vendor Strategy Work Group Lead
Siemens Healthineers Enters into Agreement with Scopio Labs to Distribute Full-Field Digital Cell Morphology Technology

Siemens Healthineers Enters into Agreement with Scopio Labs to Distribute Full-Field Digital Cell Morphology Technology

, 8 May 2023/in E-News /by panglobal

The alliance between Siemens Healthineers and Scopio Labs will revolutionize the way laboratorians view patient samples—from under a microscope to digitized slides. Scopio Labs has granted to Siemens Healthineers global rights to distribute the Scopio X100 and Scopio X100HT, digital solutions that offer full-field imaging and an AI-powered Decision Support System with remote viewing capabilities. […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/05/Scopio-both-units-with-monitor-overlap-PBS.jpg 1519 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-05-08 18:49:532023-05-08 18:49:53Siemens Healthineers Enters into Agreement with Scopio Labs to Distribute Full-Field Digital Cell Morphology Technology
SHL medical

SHL Medical and MoonLake Immunotherapeutics collaborate to develop sonelokimab autoinjector

, 5 May 2023/in E-News /by panglobal

SHL Medical, a world-leading provider of advanced drug delivery solutions, announced that it has signed a collaboration agreement with MoonLake Immunotherapeutics, a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, to develop an autoinjector for clinical and potential commercial supply of MoonLake’s Nanobody® sonelokimab based on SHL Medical’s Molly® autoinjector technology.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/05/SHL-medical.png 190 400 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-05-05 10:43:302023-05-05 10:44:01SHL Medical and MoonLake Immunotherapeutics collaborate to develop sonelokimab autoinjector
nanologica

Nanologica’s Product within Preparative Chromatography Reaches Quality Requirements

, 5 May 2023/in E-News /by panglobal

After successfully implementing fine-tuning in production, Nanologica’s product now meets the company’s own requirements for quality in all evaluated parameters.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/05/nanologica.png 120 532 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-05-05 10:22:232023-05-05 10:22:23Nanologica’s Product within Preparative Chromatography Reaches Quality Requirements
image001

Gyros Protein Technologies introduces Gyrolab Generic Cyno ADA Kit Reagents to support pre-clinical immunogenicity assessment

, 5 May 2023/in E-News /by panglobal

Ready-to-use kit expands range of bioanalysis kits, and enables generic detection of immune complexes in cyno samples

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/05/image001.png 66 300 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-05-05 10:13:002023-05-05 10:13:51Gyros Protein Technologies introduces Gyrolab Generic Cyno ADA Kit Reagents to support pre-clinical immunogenicity assessment
Tetra Pharm Technologies launches first product in Germany

Tetra Pharm Technologies launches first product in Germany

, 5 May 2023/in E-News /by panglobal

The Danish biotech company, Tetra Pharm Technologies, is launching its first product, XATEPA®, on the German market. XATEPA® is a pain-relieving pharmaceutical drug based on cannabinoids.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/05/tetraPharm.png 267 400 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-05-05 10:08:242023-05-05 10:08:24Tetra Pharm Technologies launches first product in Germany
Robert (Bobbie) Dressen, CEO of Medical Alley, and Brigit van Dijk – van de Reijt, CEO of the Brabant Development Agency (BOM), on behalf of ROM NL, signed a Memorandum of Understanding (MOU) in the presence of Minister Kuipers of Health, Welfare and Sport.

Minnesota and Regional Development Agencies in the Netherlands collaborate to further develop the medical technology ecosystems

, 2 May 2023/in E-News /by panglobal

Robert (Bobbie) Dressen, CEO of Medical Alley, and Brigit van Dijk – van de Reijt, CEO of the Brabant Development Agency (BOM), on behalf of ROM NL, signed a Memorandum of Understanding (MOU) in the presence of Minister Kuipers of Health, Welfare and Sport.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/05/MOU-Ondertekening.jpg 643 900 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-05-02 08:38:592023-05-02 08:38:59Minnesota and Regional Development Agencies in the Netherlands collaborate to further develop the medical technology ecosystems
Ziathpr56 image

RFID tagging technology streamlines cryogenic sample management

, 1 May 2023/in E-News /by panglobal

Ziath, a Azenta Life Sciences company, announce a revolution in cryogenic sample management – the Ri-Track Mirage 2D barcoded tube whole rack reader.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/05/Ziathpr56-image.jpg 1359 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-05-01 07:22:242023-05-01 07:38:00RFID tagging technology streamlines cryogenic sample management
MammaTyper Kits

Sysmex Europe SE has signed a multi-market EMEA distribution agreement with Cerca Biotech, the company behind the innovative breast cancer diagnostic assay – MammaTyper®

, 25 April 2023/in E-News /by panglobal

As a result of the agreement, MammaTyper® will become part of the Sysmex Life Science portfolio in 13 territories across EMEA, including the UK, Ireland and the majority of mainland Europe.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/04/MammaTyper-Kits.jpg 1442 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-04-25 17:13:082023-04-25 17:40:05Sysmex Europe SE has signed a multi-market EMEA distribution agreement with Cerca Biotech, the company behind the innovative breast cancer diagnostic assay – MammaTyper®
Page 41 of 231«‹3940414243›»
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

March 2026

CLi Cover MRCH 2026
11 March 2026

Isomorphic Labs unveils IsoDDE, a unified AI drug design engine surpassing AlphaFold 3 in biomolecular prediction

11 March 2026

Androgen testing for PCOS diagnosis

9 March 2026

DiaSys Diagnostic Systems | ACE FS

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription